2020-2027 Analysis and Review Imidazole Buffer Market

Imidazole Buffer Market

Imidazole Buffer Market By Application (High Throughput Screening, Optimization of Biomolecules and Others), By End Users (Biopharmaceutical Industry, Research Academia and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

12-05-2020 REP-HC-5081 40 Tables 110 pages Format

The imidazole buffer market was valued at USD 213.2 Mn by 2019. Rising prevalence of infectious disease and chronic disease worldwide causing huge cost associated with its healthcare burden primarily drives the imidazole buffer market. Furthermore, huge funding provided by the government healthcare agencies to academic research institute for the novel drug development will further accentuate the imidazole buffer market growth.

Imidazole Buffer Market

Imidazole is very popular in the biopharmaceutical industry and is frequently used as a buffer for pH ranging from 6.2-7.8 at 25°C. It is widely employed as a buffer in the assay of horseradish peroxide and is also used as a chelating agent for the binding of several divalent cations. Imidazole buffer is used in several biochemical enzymatic reactions and finds immense application in the detection of proteins by the reverse staining of SDS-PAGE gels.

The major segments related to the imidazole buffer market are: 

By Application (2017–2027; US$ Mn)

High Throughput Screening

Optimization of Biomolecules

Others

By End Users (2017–2027; US$ Mn)

Biopharmaceutical Industry

Research Academia

Others

Geography Segment (2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA
 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global imidazole buffer market
  • The overall segmentation of the imidazole buffer market, by application, end-users and geography is minutely studied. High throughput screening and biopharmaceutical industry are dominating the application and end-user segments respectively
  • Significant increase in the number of research and development activities pertaining to novel drug development of biological drug entity
  • Provision of huge financial assistance to academic research institutes to perform preclinical trials involved in the investigation of new drugs

Report gist?

  • The study of the global imidazole buffer market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of application and end-users and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the chemical reagent manufacturers actively engaged in the production and marketing of imidazole buffer on account of increasing demand for research and development activities in the biopharmaceutical industry
  • The report will benefit academicians engaged in the conduction of preclinical trials for the investigation of new drug development
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to imidazole buffer market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

High throughput screening is spearheading the application segment for the imidazole buffer market. The present drug molecules used for the treatment of chronic diseases are associated with drug-related side effects, high throughput screening is very critical in identifying these side effects and improving the drug pharmacodynamic profile. Optimization of biomolecules is gaining tremendous demand owing to its ability to fortify the immune system against viral infections and cancer which has a lower survival rate in the infected patients. 

The biopharmaceutical industry is currently leading the end-user segment for the imidazole buffer market. Significant increase in the number of viral infections worldwide such as Coronavirus, Ebola, Swine Flu, etc. which is associated with high mortality rate and resulted in the burgeoning requirement of novel medicines for its treatment. Research academia is expected to grow at a comfortable market growth owing to the huge funding provided by the global healthcare agencies to promote the research activities for conducting the preclinical trials related to the investigation of new drug molecules. 

North America is presently dominating the geography segment for the imidazole buffer market. The key factor responsible for its market dominance is the presence of flourishing biopharmaceutical industry segments. Government healthcare agencies such as the National Institute of Health (NIH), are constantly providing grants to the academic research institutes to promote the research and development activities pertaining to new drug development of biological molecules. Additionally the domicile of key players such as Merck KGaA, AAT Bioquest, Inc., Boston Bioproducts, Santa Cruz Biotechnology, Inc., etc further accentuates the imidazole buffer market growth in the region. Europe is presently the second-largest regional segment for the imidazole buffer market owing to the strategic partnership between the academic research institutes and biopharmaceutical companies actively engaged in the optimization of biomolecules used for in the investigation of new drugs. Asia Pacific is anticipated to be the fastest-growing regional segment for imidazole buffer market owing to the competitive environment created by the western giants to the local players engaged in the manufacturing of imidazole buffers and other chemical reagents.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.